Ian Campbell

Part of Envision Healthcare Corp., Corning Ambulance Service, Inc. is a provider of ambulance services. The company is based in Corning, NY. Corning Ambulance Service was acquired by Rural/Metro Corp., part of Envision Healthcare Corp. from October 28, 2015 on September 20, 1995.

Biacore International AB offers systems that generate data on the interactions between proteins and small molecule drug candidates. Its systems are used in pharmaceutical drug discovery, antibody characterization, proteomics, immunogenicity, biotherapeutic development and manufacture and life science research applications. The company serves research centers, pharmaceutical and biotechnology companies. Biacore International markets its products in the United States, Europe, Japan and Australia. The company was founded in 1984 and is headquartered in Uppsala, Sweden

Akubio Ltd. develops acoustic biosensor instruments. Its products are used in protein research and drug development. The company's technology based on quartz resonators delivers molecular identification and measurement of interactions in complex samples. Akubio was founded by Matthew A. Cooper in August 2001 and is headquartered in Cambridge, UK

TAP Biosystems Ltd. designs and develops automated cell culture and fermentation systems for life science research. The private company is based in Royston, UK.

Innovate UK promotes, supports and invests in technology research, development, and commercialization. The firm provides access to information about the funding and support opportunities through a range of channels. The company was founded on July 1, 2007 and is headquartered in Swindon, the United Kingdom.

PiR Group provides European Life Science Management Recruitment Services. The company offers executive search, advertising and interim position recruitment services for life sciences companies. Its key services include Interim Management, Consultancy services, Mentoring & Business Support Services, Specialist Salary Survey, and search and selection of directors and team leaders in the technical and commercial areas that include discovery, research and development, validation, compliance, quality assurance, regulatory affairs, formulation, clinical operations, human resources, and business development. PiR was founded by Maurice Herring and Carolyn Douthwaite in 1990 and is headquartered in St. Ives, UK.

Molecular Vision Ltd. develops low-cost, lab-quality, point of care, disposable diagnostic devices for medical testing. The company was founded by Donal D. C. Bradley in 2001 and is headquartered in York, the United Kingdom.

Arquer Diagnostics Ltd. develops proprietary diagnostic immunoassays for the detection of prostate and bladder cancer using urine samples. Its develops non-invasive, urine-based ELISA and Point-of Care tests meet the increased demand for cost-effective healthcare technologies that not only enhance patient care but help to reduce overall healthcare costs by improving patient outcomes. The firm will commercialise ELISA and point-of-care urine tests for prostate and bladder cancer for use in the urology clinic, hospital lab and the GP’s surgery. The company was founded by David Nicholas Miller-Jones and William Dawson in 2007 and is headquartered in Sunderland, the United Kingdom.